Clinical Significance of Smoking Cessation in Subjects With Cancer: A 30-Year Review

Florou, A.; Gkiozos, Ioannis; Tsagouli, Sophia; Souliotis, Kyriakos; Syrigos, Konstantinos

doi:10.4187/respcare.02559

Cited by 64 publications

(45 citation statements)

References 46 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Similar to other studies, smoking was associated with a high prevalence of analgesic use [41, 46, 47]. This could be due to the fact that smoking is strongly associated with having more pain [48, 49]. We also observed a significant association between obesity and consuming more prescribed analgesics.…”

Section: Discussionsupporting

confidence: 89%

Prevalence, trends, patterns and associations of analgesic use in Germany

Sarganas

Buttery

Zhuang

et al. 2015

BMC Pharmacol Toxicol

View full text Add to dashboard Cite

BackgroundDespite the public health relevance of analgesic use, large-scale studies on this topic in Germany are lacking. This study describes the prevalence, trends, associations and patterns of use of prescription and over-the-counter (OTC) analgesics, focusing on five of the most common agents: aspirin, diclofenac, ibuprofen, naproxen and paracetamol.MethodsData from two representative population-based surveys: The German National Health Interview and Examination Survey 1998 (GNHIES98 n = 7099) and the German Health Interview and Examination Survey for Adults 2008–2011 (DEGS1 n = 7091) was investigated. Information on all medicines consumed in the previous 7 days was collected via computer-assisted personal interviews with adults aged 18–79 years. Associations between analgesic use and socio-demographic and health-behaviour factors were analysed using logistic regression models.ResultsAnalgesic use has increased over the last decade from 19 to 21 %. This was exclusively due to the rise in OTC analgesic use from 10.0 to 12.2 %. Prescribed analgesic use remained constant (7.9 %). Findings from DEGS1 indicate that ibuprofen is the most commonly used analgesic followed by aspirin and paracetamol. OTC analgesic use is higher among women and smokers, but lower among older adults (65–79 years). Prescribed analgesics use is higher among women, older adults, smokers and obese adults with medium or high socio- economic status. Adults performing more than 2 h/week of physical exercise use fewer analgesics.DiscussionAmong the adult population of Germany, the prevalence of OTC analgesic use has significantly increased over the last decade. We found differences between adults consuming OTC and prescribed analgesics (or both) concerning their health behaviour and health conditions. International direct comparison between prevalence rates of analgesic use was limited due to varying availability of analgesics between countries and to methodological differences.ConclusionsAbout one in five community dwelling adults aged 18–79 years in Germany use analgesics in a given week. Considering the potential harms of analgesic use, monitoring of prevalence, patterns and determinants of use at the population level are important steps to inform disease prevention and health promotion policies.

show abstract

Section: Discussionsupporting

confidence: 89%

Prevalence, trends, patterns and associations of analgesic use in Germany

Sarganas

Buttery

Zhuang

et al. 2015

BMC Pharmacol Toxicol

View full text Add to dashboard Cite

show abstract

“…A recent study reported that, similar to depression, greater daily pain ratings were associated with lower likelihood of cessation attempts and greater use of nicotine among cancer patients [Aigner, 2016]. Additionally, continued smoking following a cancer diagnosis was associated with higher levels of pain among cancer patients, compared to former and non-smokers [Daniel, 2009; Florou, 2014]. Previous research studies have identified tobacco addiction to be a risk factor for chronic pain among general population [Shiri, 2010; Sugiyama, 2010].…”

Section: Unique Clinical Aspects and Challenges For Cancer Patientsmentioning

confidence: 99%

Treating nicotine dependence and preventing smoking relapse in cancer patients

Chang

Braith

Hitsman

et al. 2016

Expert Review of Quality of Life in Cancer Care

View full text Add to dashboard Cite

Introduction Despite the well-documented harmful effects of smoking, many cancer patients continue to smoke. Smoking cessation is critical to address in this population given the associated increase in treatment toxicity, risk of second primary tumors, decrease in treatment response and higher disease-specific and all-cause mortality with continued smoking following a cancer diagnosis. This review seeks to summarize the latest recommendations and guidelines on smoking cessation treatment for patients diagnosed with cancer, and the evidence behind those recommendations. Areas covered We reviewed the latest evidence for smoking cessation treatments for cancer patients and the clinical guidelines and recommendation available for oncologists and health care providers. The unique aspects of nicotine dependence among patients diagnosed with cancer, and key challenges and barriers that cancer survivors and health care providers experience when considering smoking cessation treatments, and available clinical resources, are also discussed. Lastly, the authors summarize future directions in the field of smoking cessation treatment for cancer patients. Expert commentary While there are areas of improvement in research of smoking cessation treatment for cancer patients, critical under-explored areas remain. Nonetheless, providers should adhere to the NCCN guidelines and offer a brief counseling intervention to motivate patients to quit smoking when appropriate resources are not available.

show abstract

“…Smoking cessation carries numerous benefits, even after a cancer diagnosis, including a greater response to cancer treatment [1, 9, 10] and reduced risk of mortality [1, 3, 9]. Cancer survivors who continue to smoke are at a higher risk than non-smoking survivors for secondary primary cancers as well as a wide range of other conditions causally associated with smoking, including diabetes, cardiovascular disease, impaired iimnune function, rheumatoid arthritis, dental disease, pain-related impairment, and more [1, 11]. Given the large population of cancer survivors who smoke and the importance of smoking cessation in tins population, a critical need exists to understand both the barriers and facilitators of smoking cessation in tins very high risk population, particularly since conventional behavioral and pharmacologic smoking cessation programs are not effective at increasing the smoking cessation in cancer survivors [12].…”

Section: Introductionmentioning

confidence: 99%

Correlates of smoking status in cancer survivors

et al. 2018

View full text Add to dashboard Cite

Purpose: To determine the characteristics associated with cancer survivors which indicate continued cigarette smoking at or around the time of cancer diagnosis. Methods: 631 survivors were recruited in four cancer centers in Memphis, TN, between March 2015 and June 2016. To increase the probability of accurate reporting, surveys were conducted anonymously. 112 respondents reported they were current smokers and 202 reported they were former smokers (n=314), who comprised the sample. Results: We found that the rate of daily e-cigarette use among cancer survivors who smoked was 15.2% versus 3.9% in cancer survivors who no longer smoked. (The national rate of adult e-cigarette use is 3.5%.) Multivariate models correlated the characteristics of current versus former smokers and revealed that increasing age (aOR=0.97, p<.0001), decreasing education (aOR=2.39, p<.02) and current use of e-cigarettes (aOR=3.74, p<.00045) were frequently associated with current cigarette smoking. Conclusions: While age and gender were associated with continued smoking, current use of e-cigarettes was associated with almost four times higher odds of being a current smoker. Further research is needed to determine if use of e-cigarettes deters or promotes the smoking cessation process, at least in cancer survivors. Implications for Cancer Survivors: Among cancer survivors who continue to smoke after a cancer diagnosis, use of e-cigarettes is highly prevalent; research is needed to determine whether use of e-cigarettes promotes, has no effect, or hinders smoking cessation efforts among this vulnerable population.

show abstract

Clinical Significance of Smoking Cessation in Subjects With Cancer: A 30-Year Review

Cited by 64 publications

References 46 publications

Prevalence, trends, patterns and associations of analgesic use in Germany

Prevalence, trends, patterns and associations of analgesic use in Germany

Treating nicotine dependence and preventing smoking relapse in cancer patients

Correlates of smoking status in cancer survivors

Contact Info

Product

Resources

About